Periventricular magnetisation transfer ratio abnormalities in multiple sclerosis improve after alemtuzumab. (2020)
Attributed to:
Computational models of neurodegenerative disease progression
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1177/1352458519852093
PubMed Identifier: 31169059
Publication URI: http://europepmc.org/abstract/MED/31169059
Type: Journal Article/Review
Volume: 26
Parent Publication: Multiple sclerosis (Houndmills, Basingstoke, England)
Issue: 9
ISSN: 1352-4585